Oliver Quick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Oliver Quick has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Celia Wells
University of Bristol, UK
22 shared publications- Anita Ho
Bioethics Program University of California San Francisco (UCSF) USA
1 shared publication - Christopher Wai Hung Yau
Southmead Hospital, Bristol, UK
1 shared publication Danielle Griffiths
University of Sussex, Department of Law
1 shared publicationJames Devenney
University of Durham
1 shared publicationJenny Vaughan
Consultant Neurologist and Medical Law Campaigner
1 shared publication
Latest Publications
- 9 April 2026
- Published by Edward Elgar Publishing
- p. 143-162
Healthcare harm and the safety of informed consent
- 9 April 2026
- Published by Edward Elgar Publishing
- p. 143-162
Healthcare harm and the safety of informed consent
- Open Access
- 21 March 2022
- Published by Oxford University Press (OUP) in Medical Law Review
- Vol. 30 (2) , 324-347
Duties of Candour in Healthcare: The Truth, the Whole Truth, and Nothing but the Truth?
The creation of professional and statutory duties of candour has formalised the requirement for clinicians and healthcare organisations to be honest with patients and families when treatment has gone wrong. This article explains the background to creating both duties, analyses the concept of candour, the role of apologies, and considers evidence about compliance. It argues that making candour a statutory requirement appropriately reflects the ethical imperative of telling the truth about harm and is a powerful signal for honesty. However, being candid is not easy in the context of complex professional cultures, the realities of delivering care in under-funded health systems, and in the shadow of possible legal and regulatory proceedings. Proposals in the current Health and Care Bill to create investigatory ‘safe spaces’ which prohibit the disclosure of information submitted to the Health Service Safety Investigations Body undermine candour. This article argues against such proposals, which are both wrong in principle and highly problematic in practice. Candour should be respected as a cardinal principle governing not only the conduct of those providing care, but also those who investigate such incidents. Harmed patients and their families deserve to know the whole truth.
- 21 March 2022
- Published by Oxford University Press (OUP) in Medical Law Review
- Vol. 30 (2) , 324-347
Open AccessDuties of Candour in Healthcare: The Truth, the Whole Truth, and Nothing but the Truth?
The creation of professional and statutory duties of candour has formalised the requirement for clinicians and healthcare organisations to be honest with patients and families when treatment has gone wrong. This article explains the background to creating both duties, analyses the concept of candour, the role of apologies, and considers evidence about compliance. It argues that making candour a statutory requirement appropriately reflects the ethical imperative of telling the truth about harm and is a powerful signal for honesty. However, being candid is not easy in the context of complex professional cultures, the realities of delivering care in under-funded health systems, and in the shadow of possible legal and regulatory proceedings. Proposals in the current Health and Care Bill to create investigatory ‘safe spaces’ which prohibit the disclosure of information submitted to the Health Service Safety Investigations Body undermine candour. This article argues against such proposals, which are both wrong in principle and highly problematic in practice. Candour should be respected as a cardinal principle governing not only the conduct of those providing care, but also those who investigate such incidents. Harmed patients and their families deserve to know the whole truth.
- Open Access
- 8 March 2022
- Published by SAGE Publications in Medical Law International
- Vol. 22 (1) , 3-32
Confidentiality and public interest disclosure: A framework to evaluate UK healthcare professional regulatory guidance
Confidentiality and disclosure of information in the public interest present difficult dilemmas for healthcare practitioners and call for clear legal and regulatory guidance. The common law duty of confidence, and established exceptions to it, are shaped by medical practice and detailed guidance produced by the General Medical Council. Guidance issued by other healthcare regulators in a highly fragmented environment is at best unclear and at worst inaccurate. This article assembles and justifies a framework of evaluation against which regulators’ guidance can be assessed, focussing on the specific issue of when the duty of confidentiality can be set aside in the public interest. Comparison of statutory regulators’ guidance reveals wide variation which creates uncertainty for practitioners confused by inconsistency between guidance documents. The results of this analysis raise questions about the relationship between common law and regulatory guidance, in particular, whether it is appropriate to recognise different standards for different healthcare professions. This article argues that there is an opportunity to correct this anomaly and ensure appropriate consistency as part of a wider review of healthcare professional regulation.
- 8 March 2022
- Published by SAGE Publications in Medical Law International
- Vol. 22 (1) , 3-32
Open AccessConfidentiality and public interest disclosure: A framework to evaluate UK healthcare professional regulatory guidance
Confidentiality and disclosure of information in the public interest present difficult dilemmas for healthcare practitioners and call for clear legal and regulatory guidance. The common law duty of confidence, and established exceptions to it, are shaped by medical practice and detailed guidance produced by the General Medical Council. Guidance issued by other healthcare regulators in a highly fragmented environment is at best unclear and at worst inaccurate. This article assembles and justifies a framework of evaluation against which regulators’ guidance can be assessed, focussing on the specific issue of when the duty of confidentiality can be set aside in the public interest. Comparison of statutory regulators’ guidance reveals wide variation which creates uncertainty for practitioners confused by inconsistency between guidance documents. The results of this analysis raise questions about the relationship between common law and regulatory guidance, in particular, whether it is appropriate to recognise different standards for different healthcare professions. This article argues that there is an opportunity to correct this anomaly and ensure appropriate consistency as part of a wider review of healthcare professional regulation.
- Open Access
- 1 September 2018
- Published by Royal College of Surgeons of England in The Bulletin of the Royal College of Surgeons of England
- Vol. 100 (6) , 251-254
Medical manslaughter: where next?
The Williams Review has emphasised the need for a clear and consistent understanding of what constitutes GNM. What does this look like in practice, and what impact will it have?
- 1 September 2018
- Published by Royal College of Surgeons of England in The Bulletin of the Royal College of Surgeons of England
- Vol. 100 (6) , 251-254
Open AccessMedical manslaughter: where next?
The Williams Review has emphasised the need for a clear and consistent understanding of what constitutes GNM. What does this look like in practice, and what impact will it have?
- Open Access
- 21 March 2018
- Published by SAGE Publications in Journal of Patient Safety and Risk Management
- Vol. 23 (2) , 79-88
Clinical–insurer engagement to improve maternity safety in the UK, Ireland, Sweden and Australia
Objective: To explore different models of clinical–insurer engagement around maternity safety and to understand how state insurers could and should engage with clinical staff to improve outcomes and reduce harm. Design: Semi-structured interviews and focus groups were conducted with senior representatives from state insurers. Transcripts were analysed to identify different models of engagement. Themes were also elicited from the transcripts. A further one-day focus group allowed for clarification and elaboration of these themes. Participants: Senior representatives from state insurers in England, Scotland, Wales, Republic of Ireland, Sweden and Victoria, Australia. Results: A variety of clinical engagement activities were undertaken by the insurers. These included training on claims and risk management, hospital site visits, facilitating multi-professional network meetings and working with clinical experts to develop best practice recommendations. Some insurers engaged with frontline clinical staff through collaborative patient safety programmes. The themes (identity and size, data and research, incentivising improvement and system integration) were important for considering the role of state insurers within health systems and how insurers could engage with clinical teams. Conclusions: This study identified different examples of clinical–insurer engagement. Whilst this was encouraging, the relationships between insurers and clinical teams could be developed further. Insurers and clinical staff could still collaborate more closely and work together in improving patient outcomes. Whilst not specifically their domain, insurers do have a role in patient safety. Closer clinical collaboration may strengthen this contribution.
- 21 March 2018
- Published by SAGE Publications in Journal of Patient Safety and Risk Management
- Vol. 23 (2) , 79-88
Open AccessClinical–insurer engagement to improve maternity safety in the UK, Ireland, Sweden and Australia
Objective: To explore different models of clinical–insurer engagement around maternity safety and to understand how state insurers could and should engage with clinical staff to improve outcomes and reduce harm. Design: Semi-structured interviews and focus groups were conducted with senior representatives from state insurers. Transcripts were analysed to identify different models of engagement. Themes were also elicited from the transcripts. A further one-day focus group allowed for clarification and elaboration of these themes. Participants: Senior representatives from state insurers in England, Scotland, Wales, Republic of Ireland, Sweden and Victoria, Australia. Results: A variety of clinical engagement activities were undertaken by the insurers. These included training on claims and risk management, hospital site visits, facilitating multi-professional network meetings and working with clinical experts to develop best practice recommendations. Some insurers engaged with frontline clinical staff through collaborative patient safety programmes. The themes (identity and size, data and research, incentivising improvement and system integration) were important for considering the role of state insurers within health systems and how insurers could engage with clinical teams. Conclusions: This study identified different examples of clinical–insurer engagement. Whilst this was encouraging, the relationships between insurers and clinical teams could be developed further. Insurers and clinical staff could still collaborate more closely and work together in improving patient outcomes. Whilst not specifically their domain, insurers do have a role in patient safety. Closer clinical collaboration may strengthen this contribution.
- Open Access
- 6 March 2018
- Published by Springer Nature in BMC Medical Ethics
- Vol. 19 (1) , 1-6
Leaving patients to their own devices? Smart technology, safety and therapeutic relationships
This debate article explores how smart technologies may create a double-edged sword for patient safety and effective therapeutic relationships. Increasing utilization of health monitoring devices by patients will likely become an important aspect of self-care and preventive medicine. It may also help to enhance accurate symptom reports, diagnoses, and prompt referral to specialist care where appropriate. However, the development, marketing, and use of such technology raise significant ethical implications for therapeutic relationships and patient safety. Drawing on lessons learned from other direct-to-consumer health products such as genetic testing, this article explores how smart technology can also pose regulatory challenges and encourage overutilization of healthcare services. In order for smart technology to promote safer care and effective therapeutic encounters, the technology and its utilization must be safe. This article argues for unified regulatory guidelines and better education for both healthcare providers and patients regarding the benefits and risks of these devices.
- 6 March 2018
- Published by Springer Nature in BMC Medical Ethics
- Vol. 19 (1) , 1-6
Open AccessLeaving patients to their own devices? Smart technology, safety and therapeutic relationships
This debate article explores how smart technologies may create a double-edged sword for patient safety and effective therapeutic relationships. Increasing utilization of health monitoring devices by patients will likely become an important aspect of self-care and preventive medicine. It may also help to enhance accurate symptom reports, diagnoses, and prompt referral to specialist care where appropriate. However, the development, marketing, and use of such technology raise significant ethical implications for therapeutic relationships and patient safety. Drawing on lessons learned from other direct-to-consumer health products such as genetic testing, this article explores how smart technology can also pose regulatory challenges and encourage overutilization of healthcare services. In order for smart technology to promote safer care and effective therapeutic encounters, the technology and its utilization must be safe. This article argues for unified regulatory guidelines and better education for both healthcare providers and patients regarding the benefits and risks of these devices.
- 29 August 2017
- Published by SAGE Publications in Medico-Legal Journal
- Vol. 85 (4) , 173-181
Medical manslaughter – time for a rethink?
- 29 August 2017
- Published by SAGE Publications in Medico-Legal Journal
- Vol. 85 (4) , 173-181
Medical manslaughter – time for a rethink?
- 16 March 2017
- Published by Cambridge University Press (CUP)
- p. 128-143
Coronial Investigations and Inquests
Regulating Patient Safety - March 2017
- 16 March 2017
- Published by Cambridge University Press (CUP)
- p. 128-143
Coronial Investigations and Inquests
Regulating Patient Safety - March 2017
- 16 March 2017
- Published by Cambridge University Press (CUP)
- p. 88-107
Complaining and Claiming
Regulating Patient Safety - March 2017
- 16 March 2017
- Published by Cambridge University Press (CUP)
- p. 88-107
Complaining and Claiming
Regulating Patient Safety - March 2017
- 16 March 2017
- Published by Cambridge University Press (CUP)
- p. 68-87
Professional Regulation and Patient Safety
Regulating Patient Safety - March 2017
- 16 March 2017
- Published by Cambridge University Press (CUP)
- p. 68-87
Professional Regulation and Patient Safety
Regulating Patient Safety - March 2017